chrisvoncsefalvay/vaers-outcomes huggingface dataset:
right side of my butt hurts like nerve wise; entire right side of my body is aching; fever without knowing I had a fever; some mental foggines; This spontaneous case was reported by a physician and describes the occurrence of MUSCULOSKELETAL PAIN (right side of my butt hurts like nerve wise), FEELING ABNORMAL (some mental foggines), MYALGIA (entire right side of my body is aching) and PYREXIA (fever without knowing I had a fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2022, the patient experienced FEELING ABNORMAL (some mental foggines) and PYREXIA (fever without knowing I had a fever). On 10-Jan-2022, the patient experienced MUSCULOSKELETAL PAIN (right side of my butt hurts like nerve wise) and MYALGIA (entire right side of my body is aching). At the time of the report, MUSCULOSKELETAL PAIN (right side of my butt hurts like nerve wise) and MYALGIA (entire right side of my body is aching) had not resolved and FEELING ABNORMAL (some mental foggines) and PYREXIA (fever without knowing I had a fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The  concomitant medications on use were not provided. No treatment information was provided.
Patient describes she is experiencing fever and chills, As well as, a knot on injection arm and armpit
Afluria Quad pediatric dose 0.25 mg administered to adult pregnant woman; Afluria Quad pediatric dose 0.25 mg administered to adult pregnant woman; This spontaneous case was received on 02-Sep-2020 from physician via agency (reference number SEQW20-01174) and concerned an adult, pregnant female patient.  The patient's medical history and concomitant medications were not reported.  The patient's last menstrual period and estimated due date were not provided.   On unknown date, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine, dose: 0.25 ml, indication, route of administration, anatomical location: not reported) (explicitly coded as 'Underdose' and 'Vaccine exposure during pregnancy').   The batch number was not reported.   At the time of initial reporting on 02-Sep-2020, the patient had no adverse reactions since administration.  This case is linked to cases 202004294, 202004295 and 202004296 (due to the same reporters).  Company comment:Reportedly, Afluria Quad pediatric dose 0.25 mg was administered to adult pregnant woman (explicitly coded as 'Underdose' and 'Vaccine exposure during pregnancy'). No information about medical history and concomitant medications was provided. The patient had no adverse reactions since administration. Causality for the events of underdose and vaccine exposure during pregnancy is assessed as not related per company conventions.; Sender's Comments: Reportedly, Afluria Quad pediatric dose 0.25 mg was administered to adult pregnant woman (explicitly coded as Underdose' and Vaccine exposure during pregnancy'). No information about medical history and concomitant medications was provided. The patient had no adverse reactions since administration. Causality for the events of underdose and vaccine exposure during pregnancy is assessed as not related per company conventions.
12-14 hours after vaccine, very sore injection site arm,  fever, chills, viral syndrome symptoms and intensely sore, burning mouth. All symptoms came on simultaneously.  felt great after one dose of NSAID except for sore mouth.  Following day looked with flash light and have red based mucoid lesions multiple throughout the oral pharynx.  no trouble swallowing.  I take valtrex 1 gram daily as my dry mouth causes chronic HSV outbreaks but these are NOT hsv as there are no central ulcerations and they burn but aren't intensely painful like hsv lesions.
About 25 minutes after I received the injection I had some intense itching in that arm. The nurse gave me an ice pack. I went home and texted my doctor who told me to take Claritin and antihistamine. I had Allegra on hand so that's what I took. Last night was terrible. Today the itching is 1000 better. I also had the same reaction to my other COVID vaccinations but not as bad as this time.
shingles; some kind of rash in her torso; This is a spontaneous report from a contactable consumer. This 45-Year-old female consumer (patient) received the second dose of the Pfizer-BioNTech COVID-19 Vaccine BNT162B2 on 29Mar2021 at single dose for covid-19 immunization. Nine days after (07Apr2021), Patient reported to have had shingles (suspected, but not confirmed) or some kind of rash in her torso. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
patient fell on the floor when getting pfizer covid vaccine due to nervous and anxiety of needle/vaccine  Per mom and dad patient has history of dizzy/anxiety of all immunizations  I told patient and parents to call 911 for her but patient refused, offered her to lie down and also gave her water. I was sitting there to monitor patient for 20 to 30 minutes along with her parents  She was doing fine and wanted to go home. So I told her parents to monitor her at home if something wrong call 911 right away  Around 3 25 pm called her mom and was able to speak with patient and her mom, both stated she is doing fine  Informed patient to keep monitor for any symptoms
Patient here for well-check 11/21/06. Had vaccinations. Parent noticed left thigh swollen area, slightly red and warm to touch. Stated swelling about size of baseball, per mom. Came to office 11/24/06 for evaluation, swelling 11cmX7cm area at visit. Treated for cellulitis - Amoxicillin 400/5ml script given.
Asthma flare within 1 hour of immunization and full attack 2 days later
After 72 hours, Friday, started feeling a bit of itching all over the body, mostly during the night; Some rash on hands; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (After 72 hours, Friday, started feeling a bit of itching all over the body, mostly during the night) and RASH (Some rash on hands) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (After 72 hours, Friday, started feeling a bit of itching all over the body, mostly during the night) and RASH (Some rash on hands). At the time of the report, PRURITUS (After 72 hours, Friday, started feeling a bit of itching all over the body, mostly during the night) and RASH (Some rash on hands) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication taken.   No treatment medication was provided.   This case was linked to MOD-2021-097637 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Additional information received was no new information for this case; adverse event reported for second dose.
Eyes swell; Lips started to swell; Sore and swollen; Injection site swelling; Felt really tired during three days; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Eyes swell), LIP SWELLING (Lips started to swell), INFLAMMATION (Sore and swollen), INJECTION SITE SWELLING (Injection site swelling) and FATIGUE (Felt really tired during three days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis (Anaphylaxis with other medications.). Concurrent medical conditions included Rheumatoid arthritis and Drug allergy (Lot of medication (Unspecified)). Concomitant products included RITUXIMAB for Rheumatoid arthritis.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (Eyes swell), LIP SWELLING (Lips started to swell), INFLAMMATION (Sore and swollen), INJECTION SITE SWELLING (Injection site swelling) and FATIGUE (Felt really tired during three days). At the time of the report, EYE SWELLING (Eyes swell), LIP SWELLING (Lips started to swell), INFLAMMATION (Sore and swollen), INJECTION SITE SWELLING (Injection site swelling) and FATIGUE (Felt really tired during three days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
At the moment of injection, I was in the middle of saying that the shot wasn't that bad to the pharmacist when I started to get very lightheaded. When he pulled the needle out of my arm quite a bit of blood ran down my arm even though I wasn't on any blood thinners. Fortunately, the pharmacists got me through it and I started to feel better in a few minutes. I ended up bruising very badly at the site of the shot. It took several weeks to go away completely.   Three months later in June 2021, I have been experiencing prolonged unexplained pain in my left leg. Ultrasound showed no blood clots.
On Tuesday, April 6, 2021, about 11:45 am, I felt a sudden sharp pain in the right temple area just above eye level and about 2 inches posterior.  I also felt some dizziness and wondered if I was having a stroke or some type of arterial inflammation.  At the time I was treating a patient and wondered if I was going to have to leave to go home.  I did get through the rest of my workday but had difficulty concentrating.  I had recurring waves of pain in the same area several times that day and into the evening, was considering alerting my adult daughter that I might need to go to a hospital.  Fortunately, resting and increased fluids seemed to resolve the pain and it was mostly gone by the next day.
Pt c/o nausea, "had something to eat before and after vaccine, felt nausea" No vomiting.  "Overthinking - nervous"
Information has been received from a nurse concerning a 25 year old female patient who on 27-APR-2010, was vaccinated IM with the first 0.5 ml dose of GARDASIL (lot # not provided) in her left deltoid muscle. It was reported that "3 or 4" days later the patient developed a rash on the palm of her hand. The patient also experienced pain at the injection site. At the time of the report the patient's outcome for rash on the palm on the hand and injection site were not reported. The patient sought unspecified medical attention. Additional information has been requested.
Headache pain to inject site, headache, body aches, ftigue Narrative:  states she is pregnant; day 2 - noticed pain to injection site; day 3 - noticed headache, body ache and fatigue; day 4 - still noticed headache, body ache and fatigue; day 5 - residual of headache that resolved throughout the day; no further note of symptoms
Patient is a 68 y.o. female patient of doctor, DO with history of DM2, CKD, hypothyroid, HTN, HLD, depression, chronic pain, presented to Hospital with cough, weakness, chills, shortness of breath .  Patient did not have any hypoxia during this hospitalization.  Found to have dehydration and acute kidney injury on chronic kidney disease, given IV fluids, symptoms are improving.  She has nausea and a headache but tolerating diet.  Feels comfortable going home later this evening   Assessment and plan  Pneumonia due to COVID-19 URI symptoms resolved Positive for COVID-19 on 8/24/2023 CXR in the ED with bilateral lower lobe opacities Labs in the ED significant for COVID 19 positive, creatinine 3.57, BUN 104, bicarb 17, sodium 133, lactic acid 1.5 Received IV fluids, antibiotics discontinued Did not develop hypoxia   AKI on CKD unknown stage Severe uremia Baseline creatinine around 1.1-1.3 Renal ultrasound showed nonobstructive right intrarenal calculi with otherwise unremarkable renal ultrasound with bladder mildly distended and otherwise unremarkable.  Simple cyst measuring 2.2 x 2.7 x 2.3 cm on left kidney Creatinine on admission 3.57-- > 2.49 with HCO3 down to 16. Started bicarb gtt, acidosis resolved, back to NS Avoid nephrotoxic agents Serum creatinine continues to improve. Discontinue spironolactone Continue candesartan and hydrochlorothiazide at time of discharge Also on Jardiance for renal protection Follow-up BMP in 4 days after discharge   Type 2 diabetes mellitus without long term insulin use Continue Jardiance   Hypothyroidism Continue synthroid   HTN Restart candesartan/hydrochlorthiazide at time of discharge Patient advised to check BP twice a day. Same place, same machine, same time. Maintain log and follow up with primary care physician in 1 week. Call primary care physician office if SBP consistently >180 or <90    HLD Continue statin   Depression Continue bupropion and Latuda   Chronic pain Continue gabapentin
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  An 81-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 03Oct2022 at 15:00 as dose 5 (booster), single (Lot number: GJ6739) at the age of 80 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Sulfa" (unspecified if ongoing), notes: Known allergies: Sulfa; "Hypertension" (unspecified if ongoing); "Migraines" (unspecified if ongoing); "Arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: The patient was treated with Paxlovid from 28Jun2023 to 02Jul2023 for the treatment of Covid-19.
This is a spontaneous report from a contactable healthcare professional received via a sales representative. A 19-year-old male patient received the second dose of TRUMENBA on an unspecified date at single dose. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced fatigue, fever, headache, chills, all on an unspecified date, with outcome of recovered by the second day post-vaccination.
Per patient, within an hour of being vaccinated, her arm was in pain and felt very heavy. Shortly thereafter, a low grade fever developed in addition to body aches and pains. This was accompanied by headache. The symptoms resolved with rest and an NSAID.
The patient began having flu-like symptoms the following day after the vaccine.  Felt achy, fatigue and not wanting to get out of bed even on vacation.  That lasted for 2 weeks and still not great even now.  The patient's  spouse reported trouble walking, stumbling, falling and gait.  The patient developed a cough a few weeks ago and is currently being treated with antibiotics called in from the physician.  The patient has not see a physician for diagnosis.  I encouraged the patient to be evaluated as soon as possible
This spontaneous report as received from a female consumer refers to a patient of unknown age with shingles. On an unknown date, the patient was vaccinated with ZOSTAVAX 1 single shot (dose, strength, frequency and lot number were not reported). Other suspect therapies included PNEUMOVAX 23 (dose, strength, frequency and lot number were not reported). Concomitant therapies included LYRICA. The patient reported that on an unknown date she received PNEUMOVAX 23 and 10 days later she received ZOSTAVAX and she had been experiencing unspecified side effect (not specified). Patient reported that she attributed this effects that she took herself off of LYRICA which she had used to treat a case of shingles that she had before receiving ZOSTAVAX. The patient did not sought medical attention. Additional information is not expected because no reporter details were provided.
I missed my menstrual cycle for the months of April and May following the vaccines.  I took a pregnancy test which was negative.  I didn't think too much about it because I assumed maybe I was starting menopause early, but when I mentioned it to others, I was told missed periods are happening with the vaccines and I should report it.  I finally started my period yesterday (June 1st), lighter than usual, but 69 days since my previous period.
When I had the other 2 doses i was ok, just a bit tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "When I had the other 2 doses i was ok, just a bit tired".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fatigue, chills, slight fever and body aches next day. 2 days after injection arm has a long red slightly hard streak below injection and down towards elbow.  not a rash, just warm to the touch and tender.
onset over 2hr time period.  Developed 3" x 5" area of redness, induration, pain & itching at site of injection.  Itching spread to back, scalp.  Took about 40 mg po benadryl; then 5.5 hrs later took 25 mg benadryl.  Itching relieved.  On day 2 following onset, itching & redness but induration has improved.
2 hrs after vaccine: red edematous conjunctivae with arthragias, sweats, fever 100.5, fatigue,laryngitis, rhinnorhea. Improved in less than 24 hours. Treated with ibuprofen, benadry and 40 mg prednisone.
pt recv vax 5JUN96 & devel elevated temp, vomiting & leg stiffening p/inj;now lt SQ tissue w/white head @ site of inj;site is hard;no pain w/pressure, leg movement good;
In February 2022, I experienced a hypertensive episode where my blood pressue (which was normally in the 130/90 range, had quickly escalated and I was experiencing unusual headaches over the weekend leading up to.  I have also had the flu and shingles vaccine administered earlier around this same time.   Went to the ER as a walk-in.  No treatment was provided and was told to see PCP for hypertension.   Have since been on a low does of blood pressure medications.   Since this incident, I started to experience a handful of symptoms which has yet to be attributed to any specific illness or disease., including but not limited to:   - initially internal tremors in the finger tips when sleeping - eventual progression to pins and needles in both hands and feet - eventually progressing to throbbing sensation and pins in the palm of my hands - Muscle aches, weakness - Appearance of muscle loss in 2 month period - Eventual progression of random pricks in arms and legs.
Since receiving the Pfizer shot I have had permanent tinnitus, vascular inflammation, brain fog,  pulsating tinnitus, chronic body aches, internal brain tremors, facial neuropathy, body twitches, temperature deregulation, headaches, nerve pain, and more. This began within 30 days of receiving the 2nd dose. Prior to this shot, I could run miles, surfed, and was in great shape with zero prior medical issues. Now I cannot exercise without brain fog, and vascular pain and more. I continue to suffer daily.
This spontaneous report was received from a physician and refers to a neonate patient of unknown gender. No information regarding the patient's medical history, concomitant medications and concurrent conditions was provided. On an unknown date, between 20-APR-2017 and 11-MAY-2017, the neonate patient was vaccinated with VAQTA injection, lot # M039202, expiration date on 11-MAR-2018 (dose, route and site of vaccination were not reported). No adverse reactions were reported. Additional information has been requested.
Throat tightening, facial itch, SOB. Treated in ED. Steroids 5 day following event.
Patient had pain and swelling on a large area of left shoulder and upper arm on 9/17/19, went to the emergency room on 9/18/19 per patient.  ER physician diagnosed allergic reaction with possible cellulitis.
Pfizer-BioNTech COVID-19 Vaccine EUA: during follow-up visit sixteen days after immunization patient reports following vaccination patient experienced diahhrea, cough, fever, and muscle aches for four days. Four days after vaccination patient developed urticaria. On follow-up visit patient continues to have hives that are slowly improving but still itchy,  less shortness of breath, and no chest pain and no fever.  Patient advised to use over the counter antihistamines and follow-up arranged with allergy and immunology.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 21-JUL-2014 the patient was vaccinated subcutaneously with an expired dose of MMR II (0.5 ml, lot # H013042, expiration date 17-JUL-2014). No symptoms were reported. No PQC (product quality complaint) was involved. Additional information has been requested.
Painful, swollen joints in middle fingers started on 11/19/2014. Migratory polyarthritis still affecting functioning: knees, shoulders, fingers, hands, neck, foot, toes, ankles.
myocarditis.  Positive troponin, downtrended. Neg EKG , echo.
Sinus infection got worse; Headache; Lost hearing; Had bothering tinnitus; All her body feels sick; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEAFNESS (Lost hearing) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Allergy (Allergy to Vaccine NOS). Concurrent medical conditions included Diabetes.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DEAFNESS (Lost hearing) (seriousness criterion medically significant), TINNITUS (Had bothering tinnitus), MALAISE (All her body feels sick) and HEADACHE (Headache). On an unknown date, the patient experienced SINUSITIS (Sinus infection got worse). At the time of the report, DEAFNESS (Lost hearing), TINNITUS (Had bothering tinnitus), MALAISE (All her body feels sick), SINUSITIS (Sinus infection got worse) and HEADACHE (Headache) outcome was unknown.            No concomitant medicines reported. Treatment information included unspecified antibiotic, diphenhydramine and prednisone. Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.  Action taken with the drug in response to the events was not applicable.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded.
FEVER,HIVES ALL OVER THE BODY, INCLUDING THE MOUTH ULCER, TONGUE, CRYING DAY AND NIGHTS, NO EATING, FOUR DAYS ALREADY.